Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group

被引:244
|
作者
Worm, S. W. [1 ]
Friis-Moller, N. [1 ]
Sabin, C. A. [1 ]
Sjol, A. [1 ]
Lundgren, J. D. [1 ]
Salbol-Brandt, R. [1 ]
Rickenbach, M. [1 ]
Pezzotti, P. [1 ]
Krum, E. [1 ]
Gras, L. [1 ]
Balestre, E. [1 ]
Sundstroem, A. [1 ]
Delforge, M. [1 ]
Fontas, E. [1 ]
Torres, F. [1 ]
Petoumenos, K. [1 ]
Kjaer, J. [1 ]
Collins, S. [1 ]
Storpher, S. [1 ]
Pearce, G. [1 ]
Rode, R. [1 ]
Weller, I. [1 ]
机构
[1] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
death; modifiable risk factors; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; GENERAL-POPULATION; MORTALITY; OUTCOMES; COHORT; AIDS; INTERRUPTION; INFECTION;
D O I
10.1097/QAD.0b013e32833a0918
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate any emerging trends in causes of death amongst HIV-positive individuals in the current cART era, and to investigate the factors associated with each specific cause of death. Design: An observational multicentre cohort study. Methods: All HIV-positive individuals included in one of the cohorts in the Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study were included. The association between HIV-specific and non HIV-specific risk factors and death were studied using multivariable Poisson regression. Results: We observed 2482 deaths in 180 176 person-years (PY) on 33 308 individuals [rate/1000 PY = 13.8 (95% CI 13.2-14.3)]. Primary causes of death were: AIDS (n = 743; rate/1000 PY = 4.12), liver-related (341; 1.89), CVD-related (289; 1.60), non-AIDS malignancy (286; 1.59). The overall rate of death fell from 16.9 in 1999/2000 to 9.6/1000 PY in 2007/2008. Smoking was associated with CVD and non-AIDS cancers, HBV and HCV co-infection with liver-related deaths, and hypertension with liver-related and CVD deaths. Diabetes was a risk factor for all specific causes of death except non-AIDS cancers, and higher current HIV RNA for AIDS-related deaths. Lower CD4 cell counts were associated with a higher risk of death from all specific causes of death. Conclusion: Multiple potentially modifiable traditional and HIV-specific risk factors for death of HIV-infected persons were identified. The maximum reduction in mortality in HIV-infected populations will require that each of these factors be appropriately addressed. No trends in terms of emerging causes of unexpected deaths were observed, although monitoring will continue. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1537 / 1548
页数:12
相关论文
共 47 条
  • [31] 3D-QSAR study of schizandrins for anti-HIV using comparative molecular similarity indices analysis
    Li, W
    Yi, X
    Xiao, PG
    Chu, FM
    Guo, YS
    Qiao, YJ
    Bi, KS
    Guo, ZR
    [J]. ACTA CHIMICA SINICA, 2002, 60 (07) : 1311 - 1317
  • [32] A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis
    DeWit, S
    Dupont, B
    Cartledge, JD
    Hawkins, DA
    Gazzard, BG
    Clumeck, N
    Denning, DW
    [J]. AIDS, 1997, 11 (06) : 759 - 763
  • [33] Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study
    Bang, Ulrich Christian
    Shakar, Shakil A.
    Hitz, Mette Friberg
    Jespersen, Mette Syberg
    Andersen, Ove
    Nielsen, Susanne Dam
    Jensen, Jens-Erik Beck
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (04) : 306 - 310
  • [34] Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naive patients in a single centre study
    Gedela, Keerti
    Edwards, Simon G.
    Benn, Paul
    Grant, Alison D.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (07) : 488 - 492
  • [35] HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study
    Rouet, F
    Chaix, ML
    Inwoley, A
    Msellati, P
    Viho, I
    Combe, P
    Leroy, V
    Dabis, F
    Rouzioux, C
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (01) : 34 - 40
  • [36] Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
    Podlekareva, D.
    Grint, D.
    Karpov, I.
    Rakmanova, A.
    Mansinho, K.
    Chentsova, N.
    Zeltina, I.
    Losso, M.
    Parczewski, M.
    Lundgren, J. D.
    Mocroft, A.
    Kirk, O.
    [J]. HIV MEDICINE, 2015, 16 (09) : 533 - 543
  • [37] Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study
    Androutsakos, Theodoros
    Politou, Marianna
    Boti, Sofia
    Pittaras, Theodoros
    Kontos, Athanasios
    Kordossis, Theodore
    Pouliakis, Abraham
    Panayiotakopoulos, George
    [J]. CURRENT HIV RESEARCH, 2024,
  • [38] Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
    Boyd, Mark A.
    Mocroft, Amanda
    Ryom, Lene
    Monforte, Antonella d'Arminio
    Sabin, Caroline
    El-Sadr, Wafaa M.
    Hatleberg, Camilla Ingrid
    De Wit, Stephane
    Weber, Rainer
    Fontas, Eric
    Phillips, Andrew
    Bonnet, Fabrice
    Reiss, Peter
    Lundgren, Jens
    Law, Matthew
    [J]. PLOS MEDICINE, 2017, 14 (11):
  • [39] A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T
    Knaggs, MH
    McGuigan, C
    Harris, SA
    Heshmati, P
    Cahard, D
    Gilbert, IH
    Balzarini, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2075 - 2078
  • [40] A Preliminary RCT of CBT-AD for Adherence and Depression Among HIV-Positive Latinos on the U.S.-Mexico Border: The Nuevo Día Study
    Jane M. Simoni
    John S. Wiebe
    John A. Sauceda
    David Huh
    Giselle Sanchez
    Virginia Longoria
    C. Andres Bedoya
    Steven A. Safren
    [J]. AIDS and Behavior, 2013, 17 : 2816 - 2829